Methods and compositions for inhibiting c-met dimerization and activation

Details for Australian Patent Application No. 2011202289 (hide)

Owner Genentech, Inc.

Inventors Wickramasinghe, Dineli M.; KongBeltran, Monica

Agent Griffith Hack

Pub. Number AU-A-2011202289

Parent 2004298483

Filing date 17 May 2011

Wipo publication date 9 June 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

2 June 2011 Complete Application Filed

9 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202289

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202290-RNA aptamers and methods for identi- fying the same

2011202288-Conveniently implantable sustained release drug compositions